$0.57
0.00 (-0.52%)
Open$0.59
Previous Close$0.57
Day High$0.59
Day Low$0.55
52W High$2.02
52W Low$0.39
Volume—
Avg Volume69.4K
Market Cap6.15M
P/E Ratio—
EPS$-1.06
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 189.5K | 182.3K | 1.91M |
| Net Income | -7,581,278 | -6,565,140 | 328.9K |
| Profit Margin | -4,011.7% | -3,811.2% | 17.2% |
| EBITDA | -4,304,779 | -3,934,898 | 495.2K |
| Free Cash Flow | — | — | 411.8K |
| Rev Growth | +3.9% | +3.9% | -9.8% |
| Debt/Equity | 0.27 | 0.27 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |